“; } }); // Drag and scroll functionality const playlistContainer = document.getElementById(‘playlist’); let isDown = false; let startY; let scrollTop; playlistContainer.addEventListener(‘mousedown’, (e) => { isDown = true; playlistContainer.classList.add(‘active’); playlistContainer.offsetTop; scrollTop = playlistContainer.scrollTop; }); playlistContainer.addEventListener(‘mouseleave’, () => { isDown = false; playlistContainer.classList.remove(‘active’); }); ‘, () => { isDown = false; playlistContainer.classList.remove(‘active’); playlistContainer.addEventListener(‘mousemove’, (e) => { if (!isDown) return; e.preventDefault(); const y = e.pageY -List Container playlist.offsetTop; const walk = (y – startY) * 3; // quick playlistContainer.scrollTop = scrollTop – walk; }); } } if (” !== ‘efoc24’) { // Check DoubleVerify Quality Targeting signals before rendering the player if ( ‘undefined’ !== PQ type ) { PQ.cmd.push(function () { // If DVQT signals are not available after 500 ms, render the player anyway. const timeout_id = setTimeout( jwPlayerRender, 500 ); // Get “Authentic Direct” signals. PQ.getTargeting({ signals: [‘abs’] }, function(error, targetingData) { clearTimeout(timeout_id); jwPlayerRender(error? undefined: targetingData); }); }); } else { jwPlayerRender(); } function jwPlayerRender( dvqt_signals=”” ) { let jw_ad_tag ​​= {“client”:”googima”,”adscheduleid”:”G7hR9pQ2″,”schedule”:[{“tag”:”https://pubads.g.doubleclick.net/gampad/ads?correlator=&iu=/21698916284/ess/VideoNews&env=vp&gdfp_req=1&output=vast&sz=400×300%7C640x480%7C1000x1%7C1920x1080&description_url=__page-url__&tfcd=0&npa=0&vpmute=1&vpa=auto&vad_type=linear&url=__page-url__&vpos=preroll&unviewed_position_start=1&v=4QHYeDGA&pmnd=0&pmxd=60000&ad_rule=1&cust_params=ttid%3D4QHYeDGA%26frnch%3D__item-franchise__%26environment%3Dproduction%26kwblock%3DAbb%2CCapOne%2CLincoln%2CUPS%2CVG%2CATTCric%2CDisney”,”offset”:”pre”},{“tag”:”https://vid.springserve.com/vast/670880?url=https://www.essence.com/news/watch-cynthia-erivo-on-importance-of-sisterhood/h=450&w=800&cb=1535″,”offset”:”50%”}]”offers”:{“bidders”:[{“id”:”jw-video-4QHYeDGA”,”name”:”jwdemand”,”publisherId”:”evcxFIDZ”,”siteId”:”WT5iFegj”,”placementId”:”24399785″},{“id”:”jw-video-4QHYeDGA”,”name”:”connatix”,”siteId”:”WT5iFegj”,”placementId”:”23419a80-fc77-4fd5-bd0c-2a4807a66a6c”}]”settings”:{“disableConsentManagementOnNoCmp”:true,”mediationLayerAdServer”:”dfp”,”floorPriceCents”:200,”floorPriceCurrency”:”usd”,”buckets”:[{“increment”:0.1,”max”:30,”min”:0},{“increment”:0.5,”max”:50,”min”:30}]}}}; // Configure ad tag on the fly… let additional_params = {}; // Input DVQT signals. if ( dvqt_signals && dvqt_signals.ABS.length > 0 ) { additional_params.ABS = dvqt_signals.ABS.join(“,”); } // Create a string of additional_parameters. let extra_params_str=””; for (enter additional_parameters) { let value = additional_parameters[key]; additional_params_str += `${key}=${value}`; if ( key !== Object.keys( additional_params .pop() ) { additional_params_str += ‘&’; } } // Update ad tag cust_params (must be URL encoded). if ( Object.keys( additional_parameters ). length > 0 ) { let ad_schedule = jw_ad_tag.schedule; if ( ‘undefined’ !== schedule type ads ) { for (let i = 0; i < ad_schedule.length; i++) { let ad_url = new url(jw_ad_tag.schedule[i].label); let query_params = new URLSearchParams(ad_url.search); query_params.set("cust_params", query_params.get("cust_params") + `&${additional_params_str}`); ad_url.search = query_params.toString(); jw_ad_tag.schedule[i].tag = ad_url.toString(); } } } let playerId; if ("undefined" !== type jwplayerQueue) { playerId = 'jw-video-4QHYeDGA'; jwplayerQueue.push({ 'instanceId': 'playerInstance_4QHYeDGA', 'playerId': playerId, 'config': { pid: 't6KP9zcV', playlist: "https://cdn.jwplayer.com/v2/media/4QHYeDGA", autostart: !jw_ad_tag, repeat: true, mute: true, aspect ratio: '16:9', share: {sites: ["facebook", "twitter", "email", "linkedin"]}, cast: {}, float: {disibility: true}, autoPause: {viewability: true}, displaytitle: true, displaydescription: true, controls: true, related: {displayMode: 'shelfWidget'}, interactive: {} , ad: jw_ad_tag ​​​​} }); } // Load video. jQuery(window).trigger("jw:loadplayers"); function waitForJWPlayer(callback) { if (type jwplayer !== 'undefined') { callback(); } else { setTimeout(function() { waitForJWPlayer(callback); }, 500); } } waitForJWPlayer(function() { jwplayer(playerId).on('adsManager', function (adsManagerLoaded) { let adsManager = adsManagerLoaded.adsManager; let videoElement = document.getElementById(playerId ); let config = { anId: '929481' , camp ID: '640x360', ias_xps: "autoplay", // autoplay status ias_xbp: "2", // video destination type ias_xar: "1" // autoplay status }; // Start IAS integration googleImaVansAdapter.init(google, adsManager, videoElement , configuration });

The Australian Drugs Regulatory Authority has issued an order safety warning over Phenergan and related products containing the antihistamine promethazine.

The Therapeutic Goods Administration has stated that over-the-counter products shouldn’t be given to children under six years of age due to concerns about serious unwanted side effects akin to hyperactivity, aggression and hallucinations. Breathing may turn into slow or shallow, which can be fatal.

When high doses are administered to young children, difficulties in learning and understanding, including reversible cognitive deficit and mental disability, may occur. – said the TGA.

The latest warning follows international and Australian concerns about the drug in young children, which is commonly used to treat conditions akin to hay fever and allergies, motion sickness and for short-term sedative effects.

What is promethazine?

Promethazine is a “first generation” antihistamine that has been sold over the counter in Australian pharmacies for a long time for a spread of conditions.

Unlike many other drugs, first-generation antihistamines can cross the blood-brain barrier. This means they affect your brain chemistry, making you feel drowsy and sedated.

In adults, this will likely be useful for sleep. However, in children, these drugs can cause serious unwanted side effects on the nervous system, including those mentioned on this week’s safety alert.

We’ve known about this for a while

We have known about the serious unwanted side effects of promethazine in young children for a while.

Advice regarding 20 years ago In the United States, the drug was not recommended for use in children under two years of age. In 2022, an Australian Medicines Advisory Committee made its own suggestion to increase the age to six. New Zealand released similar warnings and advice in May this 12 months.

Over the last ten years, there have been 235 cases of serious unwanted side effects from promethazine in each children and adults reported to the TGA. Of the 77 deaths reported, one was a toddler under six years of age.

Reported unwanted side effects in each adults and children included:

• 13 cases of accidental overdose (leading to 11 deaths)
• eight cases of hallucinations
• seven cases of slow or shallow respiration (leading to 4 deaths)
• six cases of decreased consciousness (leading to five deaths).

TGA security alert comes after an internal investigation by the manufacturer of Phenergan, Sanofi-Aventis Healthcare. This investigation was initiated in 2022 advice from the Medicines Advisory Committee. The company has now updated its information for consumers and healthcare professionals.

What can you use instead?

If you have allergies or hay fever in young children, non-sedating antihistamines akin to Claratine (loratadine) or Zyrtec (cetirizine) are preferred. They provide relief without the risk of sedation and other disturbing unwanted side effects of promethazine.

If symptoms of a chilly or cough occur, parents must be reassured that these symptoms will normally subside with time, fluid intake, and rest.

Saline nasal sprays, adequate hydration, a humidifier or elevating the child’s head can relieve the congestion related to hay fever. Oral products containing phenylephrine marketed for nasal congestion must be avoided because evidence shows that this is the case This article was originally published on : theconversation.com

Owner of X and candidate for the White House cabinet Elon Musk asked users to submit MRI results, CT scans and other medical information to its AI chatbotGrok reviewed it and a few people fell for it, he reports.

Musk presented this concept to X in late October 2024.

“Try uploading X-rays, PET, MRI, or other medical images to Grok for analysis. It’s still early stages, but it’s already quite accurate and will be extremely good,” he wrote. “Let us know where Grok is doing it right or where it needs work.”

Some individuals who voluntarily submitted photos were comfortable that Grok “did do well” together with his blood test results and breast cancer detection, but others waved red flags against the platform.

Josh Sharp, who goes by @showinvestment on social media, identified how a broken collarbone was viewed as a dislocated shoulder.

Radiologist Docteur TJ provided an in-depth evaluation of the MRI image, which he described partially as “too gross.”

Another example is a robot confusing a mammogram of a benign breast cyst with a picture of the testicles.

Grok was launched in May 2024 after raising $6 billion in an investment financing round through Musk’s tech startup, xAI. Grok is just not the primary of its kind: Google’s Gemini or OpenAI’s ChatGPT also enable the transfer of medical images.

While some praise the technology’s potential advances, medical privacy experts don’t not on this camp.

“It’s very personal data, and there’s no telling exactly what Grok will do with it,” said Vanderbilt University biomedical informatics professor Dr. Bradley Malin, according to “Sending personal information to Grok is more like, ‘Whee!’ Let’s throw out this data and hope the corporate does what I need it to do.”

The Health Insurance Portability and Accountability Act (HIPAA) protects medical information shared with physicians or in a patient portal because federal guidelines protect it from being shared without consent. However, the protection doesn’t cover social networking sites – it only applies to doctor’s offices, hospitals, health insurers and a few firms they work with.